Marta Lipinski

Mesenchymal stem cells as cellular factories for targeted P2X7 blockade after traumatic brain injury

Abstract Background Traumatic brain injury (TBI) causes long‐term disability, with inflammation contributing to both primary and secondary brain damage. Extracellular adenosine triphosphate (ATP) and its receptor purinergic receptor X7 (P2X7) drive neuroinflammation and represent...